Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Fisher & Paykel Healthcare Corp Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $18.17 billion
P/E Ratio 34.84
Dividend Yield 1.16%
Shares Outstanding 576.72 million
Earnings per share 0.904
Dividend per share 0.36
Year To Date Return -0.66%
Earnings Yield 2.87%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
10 Dec 2009 $0.0429 0.00% Interim 18 Dec 2009
22 Jun 2009 $0.0560 0.00% Final 06 Jul 2009

FPH ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corp Ltd (FPH) is a global designer and manufacturer of products and systems for use in a range of healthcare services. The company’s products are split into two groups: hospital and homecare.

In the hospital product group, Fisher & Paykel provides a range of humidification products such as ventilators and nasal high flow for adults and infants. Within homecare, Fisher & Paykel is a leading provider of CPAP devices and humidifiers for those who suffer from obstructive sleep apnea.

The overarching Fisher & Paykel company was established in 1934 as an importer of refrigerators and washing machines. The company’s involvement in healthcare began in 1969 when it looked to branch out and benefit from growing manufacturing and electronic expertise.

In 2001, the company split into two separate entities, healthcare and appliances. Today, Fisher & Paykel Healthcare reaches customers in more than 120 countries and its shares are listed on both the ASX and NZX.

FPH Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Sep 2021 $30.54 $0.21 0.69% 525,512 $30.36 $30.62 $30.14
15 Sep 2021 $30.33 $-0.01 -0.03% 959,730 $30.52 $30.64 $30.10
14 Sep 2021 $30.34 $-1.14 -3.62% 764,305 $31.11 $31.12 $30.24
13 Sep 2021 $31.48 $-0.14 -0.44% 322,515 $31.61 $31.83 $31.25
10 Sep 2021 $31.62 $-0.16 -0.50% 346,743 $31.77 $31.87 $31.35
09 Sep 2021 $31.78 $0.08 0.25% 587,997 $31.94 $32.12 $31.51
08 Sep 2021 $31.70 $-0.72 -2.22% 691,377 $32.53 $32.79 $31.63
07 Sep 2021 $32.42 $-0.09 -0.28% 207,010 $32.28 $32.51 $32.20
06 Sep 2021 $32.51 $0.37 1.15% 527,905 $31.97 $32.52 $31.74
03 Sep 2021 $32.14 $-0.05 -0.16% 364,489 $32.28 $32.35 $31.89
02 Sep 2021 $32.19 $0.62 1.96% 423,717 $31.54 $32.19 $31.15
01 Sep 2021 $31.57 $-0.22 -0.69% 185,760 $31.50 $31.64 $31.26
31 Aug 2021 $31.79 $0.47 1.50% 403,121 $31.86 $32.14 $31.75
30 Aug 2021 $31.32 $0.45 1.46% 418,567 $31.05 $31.48 $31.05
27 Aug 2021 $30.87 $0.00 0.00% 597,861 $30.80 $31.18 $30.56
26 Aug 2021 $30.87 $-0.20 -0.64% 406,087 $30.96 $31.20 $30.65
25 Aug 2021 $31.07 $-0.40 -1.27% 456,445 $32.09 $32.09 $31.01
24 Aug 2021 $31.47 $-0.63 -1.96% 471,671 $32.10 $32.19 $31.33
23 Aug 2021 $32.10 $-0.13 -0.40% 304,390 $32.13 $32.48 $31.84
20 Aug 2021 $32.23 $-0.03 -0.09% 348,271 $32.32 $32.48 $32.09
19 Aug 2021 $32.26 $0.26 0.81% 611,726 $31.82 $32.26 $31.66
18 Aug 2021 $32.00 $1.11 3.59% 934,802 $31.07 $32.16 $31.07

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
04 Mar 2021 Scott St John Buy 500 $14,025
As advised by the company. Purchase of Ordinary Shares
Trading in $NZD.
27 Nov 2020 Scott St John Buy 1 $48,705
As advised by the company. Purchase of Ordinary Shares
Trading in $NZD.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael Grenfell Daniell Non-Executive Director Nov 2001
Mr Daniell is a member of the Council of the University of Auckland, a director of Cochlear Limited, Tait Limited and the Medical Research Commercialisation Fund, and Chair of the Medical Technologies Centre of Research Excellence. He is a member of Risk Committee.
Mr Lewis George Gradon Chief Executive OfficerManaging Director Apr 2016
Mr Gradon during his 37-year tenure with Fisher & Paykel Healthcare he has held various engineering positions overseeing the development of our range of products as well the development of our manufacturing, quality, intellectual property, supply chain and clinical research functions.
Mr Neville Mitchell Non-Executive Director Nov 2018
Mr Mitchell was Chief Financial Officer and Company Secretary of Cochlear Limited between 1995 and 2017. He is non-executive director of Sonic Healthcare, Osprey Medical and Q'Biotics Group, a member of the Australian Board of Taxation, and a director of the South East Sydney Local Health District Board. Previously, he served on the New South Wales Medical Devices Fund, was Chairman of the Group of 100, and Chairman, Standing Committee (Accounting and Auditing), for the Australian Securities and Investments Commission. He is a member of Quality, Safety and Regulatory Committee.
Mr Donal Paul O'Dwyer Non-Executive Director Dec 2012
Mr O'Dwyer is a director of Cochlear Limited, Mesoblast Limited and nib Holdings Limited. From 1996 to 2003, he was with Cordis Cardiology, initially as its president (Europe) and from 2000 to 2003 as its worldwide president. He worked for 12 years with Baxter Healthcare, as a plant manager in Ireland & then president of the Cardiovascular Group, Europe, now Edwards Lifesciences. He is the chairman of Quality, Safety & Regulatory Committee and member of People Committee.
Ms Geraldine Celia McBride Non-Executive Director Aug 2013
Ms McBride has been in the technology industry for 30 years and has global experience. She has held senior executive roles at SAP AG and Dell Inc, and is a former President of SAP North America. She is a director of National Australia Bank and Sky Network Television Ltd, and the founder and CEO of MyWave.
Mr Scott Andrew St John Non-Executive DirectorNon-Executive Chairman Oct 2015
Mr Carter was managing director of Foodstuffs New Zealand Limited for ten years until his retirement in 2010. He is chairman of the board of TR Group and Datacom Group, a director of Vector Limited and ANZ Bank New Zealand Limited, and a trustee of the Maurice Carter Charitable Trust. He is a member of Quality, Safety & Regulatory, People and Risk Committee.
Ms Philippa (Pip) Mary Greenwood Non-Executive Director Jun 2017
Ms Greenwood is a director of Spark New Zealand Limited, Westpac New Zealand Limited and a2 Milk Company Limited, a current trustee of the Auckland Writers Festival and served as a member of the New Zealand Takeovers Panel from 2007 to 2011. She was a partner at Russell McVeagh between 2001 and 2019 and previously served as the firm's Board Chair. She has advised on market transactions. She is the chairman of People Committee.
Mr Marcus James Driller Company SecretaryVice President - Corporate
-
Marcus James Driller Company SecretaryVice President - Corporate
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Nominees (New Zealand) Limited 84,735,040 14.70%
HSBC Nominees (New Zealand) Limited I 66,978,951 11.62%
Jpmorgan Chase Bank 58,909,933 10.22%
Citibank Nominees (Nz) Ltd 41,810,783 7.25%
HSBC Custody Nominees (Australia) Limited 39,770,963 6.90%
Jpmorgan Nominees Australia Pty Limited 21,751,016 3.77%
Citicorp Nominees Pty Limited 18,666,433 3.24%
Tea Custodians Limited 15,191,575 2.64%
New Zealand Superannuation Fund Nominees Limited 12,416,669 2.15%
National Nominees New Zealand Limited 11,789,542 2.05%
Accident Compensation Corporation 9,617,415 1.67%
BNP Paribas Nominees Nz Limited Bpss40 9,391,635 1.63%
Cogent Nominees Limited 8,845,907 1.53%
Custodial Services Limited 7,542,681 1.31%
BNP Paribas Noms Pty Ltd 6,724,163 1.17%
National Nominees Limited 6,379,451 1.11%
Premier Nominees Limited 6,339,895 1.10%
FNZ Custodians Limited 6,193,852 1.07%
Custodial Services Limited I 5,953,253 1.03%
Jbwere (Nz) Nominees Limited 4,596,927 0.80%

Frequently Asked Questions

Yes. Fisher & Paykel Healthcare has paid twice yearly, unfranked dividends every year since mid-2002, the year following its initial listing on the ASX. The company paid an interim dividend of 11.48 cents per share on 19 December 2019. Fisher & Paykel Healthcare’s final dividend payment of 18.24 cents per share will be paid on 17 July 2020.

Fisher & Paykel Healthcare established a dividend reinvestment plan in 2009 however it has been suspended since May 2019 so is not currently in operation.

Profile

since

Note